Literature DB >> 15646309

The national Vitamin A Supplementation Program and subclinical vitamin A deficiency among preschool children in the philippines.

M R A Pedro1, J R Madriaga, C V C Barba, R C F Habito, A E Gana, M Deitchler, J B Mason.   

Abstract

The prevalence of vitamin A deficiency (serum retinol [SR] < 20 microg/dl) in children from one to five years of age in the Philippines rose from 35.8% to 38% between 1993 and 1998, despite a twice-yearly universal vitamin A capsule distribution program. The Philippines 1998 National Nutrition Survey, with one-time SR measurements from 11,620 children from one to four years of age, collected over an eight-month period from one month to more than six months after distribution of vitamin A capsules, was an opportunity to examine the impact of the program on the children's vitamin A status, using post hoc analysis. Overall, a detectable impact of vitamin A capsules on SR was limited to groups with the highest prevalence of vitamin A deficiency and lasted up to four months after dose administration. In highly urban cities in Visayas, where very high prevalences of deficient SR (SR < 10 microg/dl) were found, the prevalence of deficient SR was reduced from 27% to 9% one to two months after distribution of vitamin A capsules, and to 16% at three to four months. In Mindanao, a statistically significant reduction from 38% to 32% was seen in the prevalence of deficient to low SR (SR < 20 microg/dl) one to four months after distribution of vitamin A capsules. There was no overall reduction in the prevalence of vitamin A deficiency or deficient and low SR (SR < 20 microg/dl) in Luzon, but a significant interaction with stunting was observed in Luzon non-highly urbanized cities. Two aspects are of concern. First, the magnitude of the effect of high-dose vitamin A capsules on SR, and hence on the extent of reduction in deficiency, is limited. Second, the effect does not persist for six months, which is the interval between doses. Thus there is no decrease in the prevalence of deficiency over time. With more frequent dosing (especially to those most deficient in SR), a progressive reduction in vitamin A deficiency could, however, be expected; this hypothesis could be tested. The policy implication arising from these results is that a shift in resources is warranted. In areas of low prevalence of vitamin A deficiency, distribution of vitamin A capsules should be targeted to stunted children. In areas of high prevalence, vitamin A capsules should be distributed to children one to five years old at least three times a year.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15646309     DOI: 10.1177/156482650402500401

Source DB:  PubMed          Journal:  Food Nutr Bull        ISSN: 0379-5721            Impact factor:   2.069


  5 in total

Review 1.  Does India Need a Universal High-Dose Vitamin A Supplementation Program?

Authors:  Ted Greiner; John Mason; Christine Stabell Benn; H P S Sachdev
Journal:  Indian J Pediatr       Date:  2019-01-14       Impact factor: 1.967

2.  We Need Studies of the Mortality Effect of Vitamin A Supplementation, Not Surveys of Vitamin A Deficiency.

Authors:  Christine Stabell Benn
Journal:  Nutrients       Date:  2017-03-15       Impact factor: 5.717

3.  The Nutritional Impact of Milk Beverages in Reducing Nutrient Inadequacy among Children Aged One to Five Years in the Philippines: A Dietary Modelling Study.

Authors:  Tsz-Ning Mak; Imelda Angeles-Agdeppa; Marie Tassy; Mario V Capanzana; Elizabeth A Offord
Journal:  Nutrients       Date:  2020-10-29       Impact factor: 5.717

4.  Can an integrated approach reduce child vulnerability to anaemia? Evidence from three African countries.

Authors:  Kendra Siekmans; Olivier Receveur; Slim Haddad
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

5.  Child acceptability of a novel provitamin A carotenoid, iron and zinc-rich complementary food blend prepared from pumpkin and common bean in Uganda: a randomised control trial.

Authors:  Edward Buzigi; Kirthee Pillay; Muthulisi Siwela
Journal:  BMC Pediatr       Date:  2020-09-01       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.